Adjuvant endocrine therapy: Controversies and perspectives

Keyphrases

• Selective Estrogen Receptor Modulators 100%
• Adjuvant Endocrine Therapy 100%
• Breast Cancer 50%
• Chemotherapy 50%
• Invasive Breast Cancer 50%
• Therapeutic Potential 50%
• Axillary Lymph Node 50%
• New Therapeutics 50%
• Menopausal Status 50%
• Survival Benefit 50%
• Node-negative 50%
• Lymph Node Positive 50%
• Estrogen Receptor-positive Breast Cancer 50%
• Cancer 2 50%
• St. Gallen 50%
• Large Amount of Data 50%
• Consensus Development Conference 50%
• Safety Self-efficacy 50%
• Efficacy-toxicity 50%
• View-sharing 50%
• Ovarian Ablation 50%
• Hormone Receptor-positive Breast Cancer 50%
• Tamoxifen Therapy 50%

Medicine and Dentistry

• Tamoxifen 100%
• Adjuvant Endocrine Therapy 100%
• Breast Cancer 75%
• Selective Estrogen Receptor Modulator 50%
• Disease 25%
• Estrogen Receptor 25%
• Hormone Receptor 25%
• Catheter Ablation 25%
• Axillary Lymph Node 25%
• Estrogen Receptor Positive Breast Cancer 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Tamoxifen 100%
• Endocrine Therapy 100%
• Breast Cancer 75%
• Selective Estrogen Receptor Modulator 50%
• Disease 25%
• Estrogen Receptor 25%
• Chemotherapy 25%
• Hormone Receptor 25%
• Estrogen Receptor Positive Breast Cancer 25%